These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18410043)

  • 1. Recognition and identification of UV-absorbing leachables in EPREX pre-filled syringes: an unexpected occurrence at a formulation-component interface.
    Pang J; Blanc T; Brown J; Labrenz S; Villalobos A; Depaolis A; Gunturi S; Grossman S; Lisi P; Heavner GA
    PDA J Pharm Sci Technol; 2007; 61(6):423-32. PubMed ID: 18410043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes.
    Boven K; Stryker S; Knight J; Thomas A; van Regenmortel M; Kemeny DM; Power D; Rossert J; Casadevall N
    Kidney Int; 2005 Jun; 67(6):2346-53. PubMed ID: 15882278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epoetin-associated pure red cell aplasia in patients with chronic kidney disease: solving the mystery.
    Boven K; Knight J; Bader F; Rossert J; Eckardt KU; Casadevall N
    Nephrol Dial Transplant; 2005 May; 20 Suppl 3():iii33-40. PubMed ID: 15824129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epoetin-associated pure red cell aplasia: past, present, and future considerations.
    McKoy JM; Stonecash RE; Cournoyer D; Rossert J; Nissenson AR; Raisch DW; Casadevall N; Bennett CL
    Transfusion; 2008 Aug; 48(8):1754-62. PubMed ID: 18482185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pure red-cell aplasia "epidemic"--mystery completely revealed?
    Locatelli F; Del Vecchio L; Pozzoni P
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S303-7. PubMed ID: 17556324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of polysorbate 80 with erythropoietin: a case study in protein-surfactant interactions.
    Villalobos AP; Gunturi SR; Heavner GA
    Pharm Res; 2005 Jul; 22(7):1186-94. PubMed ID: 16028020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the immuno-stimulatory potential of stopper extractables and leachables by using dendritic cells as readout.
    Mueller R; Karle A; Vogt A; Kropshofer H; Ross A; Maeder K; Mahler HC
    J Pharm Sci; 2009 Oct; 98(10):3548-61. PubMed ID: 19226629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating Serious Adverse Drug Reactions in Patients Receiving Erythropoiesis-Stimulating Agents: A Root Cause Analysis Using the "ANTICIPATE" Framework.
    Jacob S; Nichols J; Macdougall IC; Qureshi Z; Chen B; Yang YT; Norris LB; Bennett CL
    Am J Ther; 2018; 25(6):e670-e674. PubMed ID: 30169374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure red-cell aplasia and epoetin therapy.
    Bennett CL; Luminari S; Nissenson AR; Tallman MS; Klinge SA; McWilliams N; McKoy JM; Kim B; Lyons EA; Trifilio SM; Raisch DW; Evens AM; Kuzel TM; Schumock GT; Belknap SM; Locatelli F; Rossert J; Casadevall N
    N Engl J Med; 2004 Sep; 351(14):1403-8. PubMed ID: 15459301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epoetins: differences and their relevance to immunogenicity.
    Haselbeck A
    Curr Med Res Opin; 2003; 19(5):430-2. PubMed ID: 13678480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS).
    Macdougall IC; Casadevall N; Locatelli F; Combe C; London GM; Di Paolo S; Kribben A; Fliser D; Messner H; McNeil J; Stevens P; Santoro A; De Francisco AL; Percheson P; Potamianou A; Foucher A; Fife D; Mérit V; Vercammen E;
    Nephrol Dial Transplant; 2015 Mar; 30(3):451-60. PubMed ID: 25239637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of risk.
    Cournoyer D; Toffelmire EB; Wells GA; Barber DL; Barrett BJ; Delage R; Forrest DL; Gagnon RF; Harvey EA; Laneuville P; Patterson BJ; Poon MC; Posen GA; Messner HA;
    J Am Soc Nephrol; 2004 Oct; 15(10):2728-34. PubMed ID: 15466278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pure red cell aplasia with anti-erythropoietin antibodies occurs more commonly with one formulation of epoetin alfa than another.
    Macdougall IC
    Curr Med Res Opin; 2004 Jan; 20(1):83-6. PubMed ID: 14741076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of leachables observed in the size exclusion chromatograms of a low concentration product stored in prefilled syringes.
    Valente JJ; Peddicord MB; Rinaldi FA; Kelly KA; Bolgar MS
    J Pharm Biomed Anal; 2017 May; 139():133-142. PubMed ID: 28279928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project.
    Bennett CL; Cournoyer D; Carson KR; Rossert J; Luminari S; Evens AM; Locatelli F; Belknap SM; McKoy JM; Lyons EA; Kim B; Sharma R; Costello S; Toffelmire EB; Wells GA; Messner HA; Yarnold PR; Trifilio SM; Raisch DW; Kuzel TM; Nissenson A; Lim LC; Tallman MS; Casadevall N
    Blood; 2005 Nov; 106(10):3343-7. PubMed ID: 16099877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epoetin alfa (Eprex): reports of pure red blood cell aplasia.
    Wooltorton E
    CMAJ; 2002 Feb; 166(4):480. PubMed ID: 11873930
    [No Abstract]   [Full Text] [Related]  

  • 17. Pure red-cell aplasia induced by anti-erythropoietin antibodies in peritoneal dialysis.
    Coronel F; García-Mena M; Martínez R
    Clin Nephrol; 2004 Feb; 61(2):155-8. PubMed ID: 14989637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Treatment of Antibody-mediated Pure Red Cell Aplasia Induced by Continuous Erythropoietin Receptor Activator with Prednisolone.
    Okahashi N; Kubo M; Hoshino E; Uchihara M; Amano I; Tanaka H
    Intern Med; 2022 Jul; 61(14):2209-2213. PubMed ID: 34980800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eprex-associated pure red cell aplasia and leachates.
    Schellekens H; Jiskoot W
    Nat Biotechnol; 2006 Jun; 24(6):613-4. PubMed ID: 16763579
    [No Abstract]   [Full Text] [Related]  

  • 20. Epoetin-induced autoimmune pure red cell aplasia.
    Casadevall N
    Hematol J; 2004; 5 Suppl 3():S104-9. PubMed ID: 15190289
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.